Who is sponsoring NCT01683513?

NCT01683513 is sponsored by AZ Jan Palfijn Gent.

What condition does NCT01683513 study?

NCT01683513 studies Infertility, PCOS.

What drugs are being tested in NCT01683513?

Interventions: GnRh agonist +1500E hCG.

What is the status of NCT01683513?

NCT01683513 is currently COMPLETED.

Last reviewed 2021-02-01 · How we verify

Prospective Randomized Trial on GnRH Agonist Triggering Versus hCG Triggering in IVF Stimulation in PCOS Patients

NCT01683513 Phase 4 COMPLETED

In this study the investigators compare the traditional way of triggering with a new way in patients with Poly Cystic Ovary Syndrome (PCOS). This to reduce the risque of Ovary Hyper Stimulation Syndrome (OHSS) in In Vitro Fertilization/ IntraCytoplastic Sperm Injection (IVF/ ICSI) treatment. The investigators also compare the number of mature oocytes, embryo's and pregnancy rate.

Details

Lead sponsor	AZ Jan Palfijn Gent
Phase	Phase 4
Status	COMPLETED
Enrolment	120
Start date	2011-11
Completion	2015-02

Conditions

Infertility
PCOS

Interventions

GnRh agonist +1500E hCG

Primary outcomes

MII oocytes — patients will be followed during the stimulation with an average of 10 days
The number of mature oocytes retrieved after stimulation without creating OHSS
2 Pro Nuclei (2PN) fertilization — 24h after ICSI
laboratory follow up of the fertilized egg during the first 24h

Countries

Belgium